[Glutarladehyde-pollen-tyrosine hyposensitization. Course control of therapy using RIST and RAST].
The efficiency of the glutaraldehyd-pollen-tyrosin vaccine was controled by determination of total IgE and IgE antibodies against grass-pollens every two weeks. In addition the clinical state was checked. Patients who suffered from an allergy to grass-pollens only were free of symptoms after therapy. To proof this, a test is necessary since the case history is unreliable in 10% of persons.
D000906:Antibodies; D003888:Desensitization, Immunologic / Q000379:methods*; D004341:Drug Evaluation; D005500:Follow-Up Studies; D005976:Glutaral / Q000627:therapeutic use; D006801:Humans; D007073:Immunoglobulin E; D007167:Immunotherapy / Q000379:methods; D011058:Pollen; D011852:Radioallergosorbent Test; D011864:Radioimmunosorbent Test; D006255:Rhinitis, Allergic, Seasonal / Q000175:diagnosis / Q000188:drug therapy / Q000628:therapy*; D012621:Seasons; D014443:Tyrosine / Q000627:therapeutic use
D000906:Antibodies; D007073:Immunoglobulin E; D014443:Tyrosine; D005976:Glutaral
Glutaraldehyd-Pollen-Tyrosin-Hyposensibilisierung. Kontrolle des Therapieverlaufes durch RIST und RAST